Measles Surveillance in Tuscany (Italy), 2019–2024: A Six-Year Epidemiological Analysis
Vaccines · 25.06.2026 · 14 (7) · 558
DOI: 10.3390/vaccines14070558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 25.06.2026. Verfasst von Manuela Chiavarini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Florence, 50134 Florence, Italy. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite sustained public-health efforts, measles continues to re-emerge in Europe. According to the ECDC, 1045 measles cases were reported in Italy in 2024. We describe epidemiological trends and characteristics of measles cases in the Tuscany Region from 2019 to 2024.
Methods
We conducted a population-based retrospective study using cases reported through the national surveillance system (PREMAL). Incidence rates were calculated using demographic data from the Italian National Institute of Statistics (ISTAT). Cases were stratified by year, sex, age group, vaccination status (2024), and hospital admission; temporal, demographic, and clinical trends were analysed.
Results
From 2019 to 2024, 204 cases were reported, corresponding to a mean annual incidence of 0.93 per 100,000 population (95% CI: 0.80–1.07) and a cumulative incidence of 5.58 per 100,000 (95% CI: 4.78–6.31). Females accounted for 63.2% of cases (n = 129). After a peak in 2019 (n = 116), with an incidence of 3.13 per 100,000 (95% CI: 2.56–3.71), cases sharply declined during 2020–2023, followed by a resurgence in 2024 (n = 75), with an incidence of 2.05 per 100,000 (95% CI: 1.59–2.51). Children aged 0–4 years represented 7.4% of cases but had the highest age-specific incidence (12.19 per 100,000). Adults aged 25–64 years accounted for 70.1% of all cases, indicating the greatest absolute burden. Incidence was higher among individuals aged 25–44 years (11.56 per 100,000) than among those aged 45–64 years (4.30 per 100,000). Overall, 41.7% of cases required hospitalization. In 2024, most cases occurred in unvaccinated individuals (n = 56), while vaccination status was unknown for five cases.
Conclusions
The 2024 measles resurgence in Tuscany mainly affected unvaccinated adults. These findings highlight persistent immunity gaps among adults, suggesting that protection and prevention measures are also needed in the population (0–4 y).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, University of Florence, 50134 Florence, Italy.
- School of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
- Azienda USL Toscana Centro, 50122 Florence, Italy.
- Regione Toscana, Direzione Sanità, Welfare e Coesione Sociale, 50127 Florence, Italy.
ORCID-Profile: Manuela Chiavarini, Andrea Guida, Giulia Napoli, Paolo Bonanni, Sara Boccalini, Angela Bechini
Zitieren
APA
Chiavarini, M., Romano, R., Guida, A., Morelli, E., Di Nizio, C., Picchi, T. V., Napoli, G., Murolo, R., Filieri, V., Porchia, B. R., Senatore, D., Bianco, G., Bonanni, P., Boccalini, S., & Bechini, A. (2026). Measles Surveillance in Tuscany (Italy), 2019–2024: A Six-Year Epidemiological Analysis. Vaccines, 14(7), 558. https://doi.org/10.3390/vaccines14070558
Vancouver
Chiavarini M, Romano R, Guida A, Morelli E, Di Nizio C, Picchi TV, et al. Measles Surveillance in Tuscany (Italy), 2019–2024: A Six-Year Epidemiological Analysis. Vaccines. 2026;14(7):558. doi:10.3390/vaccines14070558
BibTeX
@article{Chiavarini2026,
author = {Chiavarini, Manuela and Romano, Rossella and Guida, Andrea and Morelli, Elena and Di Nizio, Camillo and Picchi, Teresa Vladina and Napoli, Giulia and Murolo, Roberta and Filieri, Vittorio and Porchia, Barbara Rita and Senatore, Daniela and Bianco, Giovanna and Bonanni, Paolo and Boccalini, Sara and Bechini, Angela},
title = {Measles Surveillance in Tuscany (Italy), 2019–2024: A Six-Year Epidemiological Analysis},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {7},
pages = {558},
doi = {10.3390/vaccines14070558}
}
EUVIMED